Tag Archives: Pharmaceutical Industry

Takeda shareholders approve $59 billion Shire buy but are wary of debt load

Takeda buying Shire
– Takeda’s deal to buy London-listed Shire is the biggest overseas acquisition by a Japanese company.
– It’s also one of the most indebted, with the company having secured $30.9 billion in bank loans.
– Takeda shares have fallen 25 percent since it revealed interest in buying Shire — they closed up 1 percent at on Wednesday.

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

Takeda will be joining the ranks of the world’s top 10 drugmakers and gaining expertise in rare diseases through the deal, the biggest overseas acquisition by a Japanese company.

‘Body on a chip’ promises improved drug evaluation

Engineers at MIT (Cambridge, MA) say they have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans.

The researchers used microfluidic technology – the science of manipulating and controlling fluids inside micrometer-sized channels – to create a platform that connects engineered tissues from up to ten organs. The platform allowed the researchers to accurately replicate human organ interactions for weeks at a time, allowing them to measure the effects of drugs on different parts of the body, and offering the potential to reveal whether a drug that is intended to treat one organ will have adverse effects on another.

Click here for more…

Blockchain surge could save pharma billions

Blockchain pharmaGartner Research has predicted business value from blockchain technology will total slightly more than $176 billion by 2025, then surge to exceed $3.1 trillion just five years later.

Given blockchain’s peer-to-peer transactional capabilities, those growth projections signify huge potential disruption for many industries, especially pharmaceuticals. I found out how Merck & Co. is getting ahead of the pack during my VIDEO interview with company leaders at SAP TechEd in Las Vegas.
Click here for more…

Title II of the Drug Quality and Security Act